SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| ROCE(%) | 18.77 | 10.98 | 9.68 | 13.72 | 13.28 |
What is the latest Return on Capital Employed (ROCE) ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 18.77 |
| Mar2024 | 10.98 |
| Mar2023 | 9.68 |
| Mar2022 | 13.72 |
| Mar2017 | 13.28 |
How is Return on Capital Employed (ROCE) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 18.77 | 70.95 | |
| Mar2024 | 10.98 | 13.43 | |
| Mar2023 | 9.68 | -29.45 | |
| Mar2022 | 13.72 | 3.31 | |
| Mar2017 | 13.28 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,404.4 Cr | -2.2% | -6.4% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,536.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,753.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,650.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹122,143.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,244.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.2% |
-6.4% |
-32.1% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses